Results 101 to 110 of about 6,009 (196)

Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act [PDF]

open access: yes
With substantial fixed costs of drug development, more common conditions can support more products. If additional pharmaceutical products are beneficial, they will attract greater consumption and promote better health, e.g. greater longevity.
Frank R. Lichtenberg, Joel Waldfogel
core  

Retinoid receptors in ovarian cancer: expression and prognosis [PDF]

open access: yes, 2017
Background: Ovarian cancer is frequently lethal despite aggressive multimodal therapy, and new therapies are therefore needed. Retinoids are potential candidate drugs: they prevent the development of ovarian carcinoma and enhance the efficacy of ...
Aebi, S.   +3 more
core  

Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic [PDF]

open access: yes, 2019
Brown, Powel H.   +2 more
core   +1 more source

Ulcerated nodules in a sporotrichoid distribution. [PDF]

open access: yes, 2019
de Feraudy, Sebastien   +5 more
core  

Management of Mycosis Fungoides With Chlormethine Hydrochloride Gel in Combination With Systemic Therapies: A Case Series. [PDF]

open access: yesCase Rep Dermatol Med
Dobos G   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy